A growing number of studies have identified AURKA as a key player in different types of cancers, such as gastrointestinal and pancreatic cancers, and it has been proposed as a molecular therapeutic target for tumorigenesis (92, 93). This evidence concerns the gene AURKA and familial pancreatic carcinoma.